The Influence of Type 2 Diabetes-Associated Factors on Type 1 Diabetes

Maria J. Redondo, Carmella Evans-Molina, Andrea K. Steck, Mark A. Atkinson, Jay Sosenko

Research output: Contribution to journalArticle

Abstract

Current efforts to prevent progression from islet autoimmunity to type 1 diabetes largely focus on immunomodulatory approaches. However, emerging data suggest that the development of diabetes in islet autoantibody-positive individuals may also involve factors such as obesity and genetic variants associated with type 2 diabetes, and the influence of these factors increases with age at diagnosis. Although these factors have been linked with metabolic outcomes, particularly through their impact on β-cell function and insulin sensitivity, growing evidence suggests that they might also interact with the immune system to amplify the autoimmune response. The presence of factors shared by both forms of diabetes contributes to disease heterogeneity and thus has important implications. Characteristics that are typically considered to be nonimmune should be incorporated into predictive algorithms that seek to identify at-risk individuals and into the designs of trials for disease prevention. The heterogeneity of diabetes also poses a challenge in diagnostic classification. Finally, after clinically diagnosing type 1 diabetes, addressing nonimmune elements may help to prevent further deterioration of β-cell function and thus improve clinical outcomes. This Perspectives in Care article highlights the role of type 2 diabetes-associated genetic factors (e.g., gene variants at transcription factor 7-like 2 [TCF7L2]) and obesity (via insulin resistance, inflammation, β-cell stress, or all three) in the pathogenesis of type 1 diabetes and their impacts on age at diagnosis. Recognizing that type 1 diabetes might result from the sum of effects from islet autoimmunity and type 2 diabetes-associated factors, their interactions, or both affects disease prediction, prevention, diagnosis, and treatment.

Original languageEnglish (US)
Pages (from-to)1357-1364
Number of pages8
JournalDiabetes care
Volume42
Issue number8
DOIs
StatePublished - Aug 1 2019

Fingerprint

Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus
Autoimmunity
Insulin Resistance
T Cell Transcription Factor 1
Obesity
Autoantibodies
Immune System
Inflammation
Genes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Advanced and Specialized Nursing

Cite this

Redondo, M. J., Evans-Molina, C., Steck, A. K., Atkinson, M. A., & Sosenko, J. (2019). The Influence of Type 2 Diabetes-Associated Factors on Type 1 Diabetes. Diabetes care, 42(8), 1357-1364. https://doi.org/10.2337/dc19-0102

The Influence of Type 2 Diabetes-Associated Factors on Type 1 Diabetes. / Redondo, Maria J.; Evans-Molina, Carmella; Steck, Andrea K.; Atkinson, Mark A.; Sosenko, Jay.

In: Diabetes care, Vol. 42, No. 8, 01.08.2019, p. 1357-1364.

Research output: Contribution to journalArticle

Redondo, MJ, Evans-Molina, C, Steck, AK, Atkinson, MA & Sosenko, J 2019, 'The Influence of Type 2 Diabetes-Associated Factors on Type 1 Diabetes', Diabetes care, vol. 42, no. 8, pp. 1357-1364. https://doi.org/10.2337/dc19-0102
Redondo, Maria J. ; Evans-Molina, Carmella ; Steck, Andrea K. ; Atkinson, Mark A. ; Sosenko, Jay. / The Influence of Type 2 Diabetes-Associated Factors on Type 1 Diabetes. In: Diabetes care. 2019 ; Vol. 42, No. 8. pp. 1357-1364.
@article{9f4efc39cd5245e8967290824bc0bae9,
title = "The Influence of Type 2 Diabetes-Associated Factors on Type 1 Diabetes",
abstract = "Current efforts to prevent progression from islet autoimmunity to type 1 diabetes largely focus on immunomodulatory approaches. However, emerging data suggest that the development of diabetes in islet autoantibody-positive individuals may also involve factors such as obesity and genetic variants associated with type 2 diabetes, and the influence of these factors increases with age at diagnosis. Although these factors have been linked with metabolic outcomes, particularly through their impact on β-cell function and insulin sensitivity, growing evidence suggests that they might also interact with the immune system to amplify the autoimmune response. The presence of factors shared by both forms of diabetes contributes to disease heterogeneity and thus has important implications. Characteristics that are typically considered to be nonimmune should be incorporated into predictive algorithms that seek to identify at-risk individuals and into the designs of trials for disease prevention. The heterogeneity of diabetes also poses a challenge in diagnostic classification. Finally, after clinically diagnosing type 1 diabetes, addressing nonimmune elements may help to prevent further deterioration of β-cell function and thus improve clinical outcomes. This Perspectives in Care article highlights the role of type 2 diabetes-associated genetic factors (e.g., gene variants at transcription factor 7-like 2 [TCF7L2]) and obesity (via insulin resistance, inflammation, β-cell stress, or all three) in the pathogenesis of type 1 diabetes and their impacts on age at diagnosis. Recognizing that type 1 diabetes might result from the sum of effects from islet autoimmunity and type 2 diabetes-associated factors, their interactions, or both affects disease prediction, prevention, diagnosis, and treatment.",
author = "Redondo, {Maria J.} and Carmella Evans-Molina and Steck, {Andrea K.} and Atkinson, {Mark A.} and Jay Sosenko",
year = "2019",
month = "8",
day = "1",
doi = "10.2337/dc19-0102",
language = "English (US)",
volume = "42",
pages = "1357--1364",
journal = "Diabetes Care",
issn = "1935-5548",
publisher = "American Diabetes Association Inc.",
number = "8",

}

TY - JOUR

T1 - The Influence of Type 2 Diabetes-Associated Factors on Type 1 Diabetes

AU - Redondo, Maria J.

AU - Evans-Molina, Carmella

AU - Steck, Andrea K.

AU - Atkinson, Mark A.

AU - Sosenko, Jay

PY - 2019/8/1

Y1 - 2019/8/1

N2 - Current efforts to prevent progression from islet autoimmunity to type 1 diabetes largely focus on immunomodulatory approaches. However, emerging data suggest that the development of diabetes in islet autoantibody-positive individuals may also involve factors such as obesity and genetic variants associated with type 2 diabetes, and the influence of these factors increases with age at diagnosis. Although these factors have been linked with metabolic outcomes, particularly through their impact on β-cell function and insulin sensitivity, growing evidence suggests that they might also interact with the immune system to amplify the autoimmune response. The presence of factors shared by both forms of diabetes contributes to disease heterogeneity and thus has important implications. Characteristics that are typically considered to be nonimmune should be incorporated into predictive algorithms that seek to identify at-risk individuals and into the designs of trials for disease prevention. The heterogeneity of diabetes also poses a challenge in diagnostic classification. Finally, after clinically diagnosing type 1 diabetes, addressing nonimmune elements may help to prevent further deterioration of β-cell function and thus improve clinical outcomes. This Perspectives in Care article highlights the role of type 2 diabetes-associated genetic factors (e.g., gene variants at transcription factor 7-like 2 [TCF7L2]) and obesity (via insulin resistance, inflammation, β-cell stress, or all three) in the pathogenesis of type 1 diabetes and their impacts on age at diagnosis. Recognizing that type 1 diabetes might result from the sum of effects from islet autoimmunity and type 2 diabetes-associated factors, their interactions, or both affects disease prediction, prevention, diagnosis, and treatment.

AB - Current efforts to prevent progression from islet autoimmunity to type 1 diabetes largely focus on immunomodulatory approaches. However, emerging data suggest that the development of diabetes in islet autoantibody-positive individuals may also involve factors such as obesity and genetic variants associated with type 2 diabetes, and the influence of these factors increases with age at diagnosis. Although these factors have been linked with metabolic outcomes, particularly through their impact on β-cell function and insulin sensitivity, growing evidence suggests that they might also interact with the immune system to amplify the autoimmune response. The presence of factors shared by both forms of diabetes contributes to disease heterogeneity and thus has important implications. Characteristics that are typically considered to be nonimmune should be incorporated into predictive algorithms that seek to identify at-risk individuals and into the designs of trials for disease prevention. The heterogeneity of diabetes also poses a challenge in diagnostic classification. Finally, after clinically diagnosing type 1 diabetes, addressing nonimmune elements may help to prevent further deterioration of β-cell function and thus improve clinical outcomes. This Perspectives in Care article highlights the role of type 2 diabetes-associated genetic factors (e.g., gene variants at transcription factor 7-like 2 [TCF7L2]) and obesity (via insulin resistance, inflammation, β-cell stress, or all three) in the pathogenesis of type 1 diabetes and their impacts on age at diagnosis. Recognizing that type 1 diabetes might result from the sum of effects from islet autoimmunity and type 2 diabetes-associated factors, their interactions, or both affects disease prediction, prevention, diagnosis, and treatment.

UR - http://www.scopus.com/inward/record.url?scp=85070183116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070183116&partnerID=8YFLogxK

U2 - 10.2337/dc19-0102

DO - 10.2337/dc19-0102

M3 - Article

C2 - 31167894

AN - SCOPUS:85070183116

VL - 42

SP - 1357

EP - 1364

JO - Diabetes Care

JF - Diabetes Care

SN - 1935-5548

IS - 8

ER -